103 related articles for article (PubMed ID: 9261559)
1. Increment of hFIX expression with endogenous intron 1 in vitro.
Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
[TBL] [Abstract][Full Text] [Related]
2. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX].
Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL
Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892
[TBL] [Abstract][Full Text] [Related]
3. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
Hou J; Wang J; Min B
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
[TBL] [Abstract][Full Text] [Related]
4. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
5. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
Lu D; Qiu X; Zheng B; Qiu X; Xue J
Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
[TBL] [Abstract][Full Text] [Related]
6. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
Dai YF; Qiu XF; Xue JL; Liu ZD
Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
[TBL] [Abstract][Full Text] [Related]
7. Effects of a second intron on recombinant MFG retroviral vector.
Malik AK; Wang JM; Kurachi K
Arch Virol; 2001; 146(3):601-9. PubMed ID: 11338393
[TBL] [Abstract][Full Text] [Related]
8. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
[TBL] [Abstract][Full Text] [Related]
9. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
[TBL] [Abstract][Full Text] [Related]
10. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
Krebsbach PH; Zhang K; Malik AK; Kurachi K
J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
13. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity.
Yan JB; Wang S; Huang WY; Xiao YP; Ren ZR; Huang SZ; Zeng YT
Biochem Genet; 2006 Oct; 44(7-8):349-60. PubMed ID: 17028784
[TBL] [Abstract][Full Text] [Related]
15. [The transfer and expression of human clotting factor IX in muscle mediated by electroporation].
Wang H; Wang F; Chen L; Xue J; Lu D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):476-8. PubMed ID: 11774220
[TBL] [Abstract][Full Text] [Related]
16. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
[TBL] [Abstract][Full Text] [Related]
17. A systematic study of the function of the human beta-globin introns on the expression of the human coagulation factor IX in cultured Chinese hamster ovary cells.
Haddad-Mashadrizeh A; Zomorodipour A; Izadpanah M; Sam MR; Ataei F; Sabouni F; Hosseini SJ
J Gene Med; 2009 Oct; 11(10):941-50. PubMed ID: 19565465
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
[TBL] [Abstract][Full Text] [Related]
19. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
Miao CH; Ye X; Thompson AR
Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
[TBL] [Abstract][Full Text] [Related]
20. Construction of mammary gland-specific expression vectors for human clotting factor IX and its secretory expression in goat milk.
Zhang K; Lu D; Xue J; Huang Y; Huang S
Chin J Biotechnol; 1997; 13(4):271-6. PubMed ID: 9631263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
